Table 6. EQ-5D value sets reported by clinical studies in Japan.
Value set | Status | N | Author | Published |
---|---|---|---|---|
1 | Full health | |||
0.846 | Diabetes mellitus type 2 | 220 | Sakamaki H. et al. [36] | 2006 |
0.808 | Asthma | 54 | Oga T. et al. [37] | 2003 |
0.798 | Chronic renal failure | 71 | Tajima R. et al. [34] | 2010 |
0.75 | Chronic schizophrenia | 47 | Nakamae T. et al. [35] | 2010 |
0.665 | Dementia, Alzheimer type | 72 | Hachimori A. et al. [38] | 2009 |
0.49 | Arteriosclerosis obliterans (critical limb ischemia) | 289 | Aramoto H. et al. [39] | 2003 |
0.37 | Destructive spondyloarthritis with rheumatoid arthritis | 25 | Uehara M. et al. [40] | 2012 |
0 | Death |